July 21, 2016
SARC RESEARCHERS REPORT IMMUNOTHERAPY EFFECTIVE IN SELECTED SARCOMA SUBTYPES
PRELIMINARY RESULTS OF SARC028 In this first investigator-led study of pembrolizumab in multiple subtypes of sarcoma, researchers reported encouraging results at the recent ASCO (American Society of Clinical Oncology) meeting. …
Read more